EMEA-002918-PIP01-20
Key facts
| Active substance |
Fluoride 18-labelled Prostate-Specific Membrane Antigen-1007 ([18F]PSMA-1007)
|
| Therapeutic area |
|
| Decision number |
P/0127/2021
|
| PIP number |
EMEA-002918-PIP01-20
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Visualisation of prostate specific membrane antigen in prostate cancer
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
|
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|